Weight loss medication Wegovy may soon be cheaper for thousands of people after the Pharmaceutical Benefits Advisory ...

The imminent Indian patent expiry of Novo Nordisk’s global blockbuster anti-diabetic and weight loss treatment drug – the GLP ...

Healthcare stocks haven't gotten a lot of love from investors in recent years. While the market has been strong and the S&P ...

Sacramento Telehealth Company Positions Multi-Form Compounded Semaglutide Access Through Licensed Medical Providers Ahead of ...

The arrival of GLP-1 medications like Ozempic® and Wegovy® has been nothing short of revolutionary for weight loss and diabetes management. These drugs, which include active ingredients like ...

Eli Lilly seeks FDA approval for orforglipron, a once-daily pill shown in trials to help maintain weight loss after stopping ...

Eli Lilly might have a solution for patients trying to decide whether to stay on obesity treatments forever. A study showed ...

The filing comes as Novo fights tooth-and-nail with rival Lilly to regain its footing at the top of the weight loss market.

Thousands of Australians would get access to a popular weight-loss jab on the PBS to treat obesity, under a proposal green ...

The diabetes medication semaglutide has recently become a trendy weight loss treatment. But like every drug, there are ...

Although the injectable forms of the popular GLP-1 drugs are more effective, the pills under development are both easier to ...

Topline results from the ATTAIN-MAINTAIN trial show that orforglipron, an investigational oral GLP-1 RA, helps people ...